It was a great honor to speak at the Biden Cancer Moonshot Workshop today at the Hubert Humphrey Building in Washington, DC. I had the opportunity to discuss how Dewpoint Therapeutics is leveraging condensate biology and the power of AI to tackle targets once deemed undruggable -an area with immense potential in the fight against cancer. Participating in this pivotal discussion reaffirmed the importance of our work and the need for continued innovation in cancer treatment. Excited to keep pushing the boundaries and contributing to new treatment options for patients.
🌟 Excited to Share Insights from AACR 2024! 🌟
Attended an enlightening session: "Engineering T cells to eradicate tumors," led by Philip D. Greenberg from Fred Hutchinson Cancer Center. The focus was on revolutionizing T-cell therapy to fight cancer more effectively, tackling the complex challenges and potential breakthroughs.
Dr. Greenberg's presentation underscored the power of scientific innovation in overcoming obstacles in cancer treatment. It was a motivational reminder of how far we've come and the promising future that lies ahead in oncology research.
Inspired and ready to contribute more to this vital field! Let’s connect if you're passionate about cancer research or have insights on T-cell therapy. The conversation around the future of oncology is one I'm eager to continue.
#AACR2024#CancerResearch#Oncology#Innovation#FredHutch
Melittin, a peptide found in bee venom, has shown potential in killing cancer cells through several mechanisms:
1. Membrane Disruption : Melittin integrates into the cell membranes of cancer cells, creating pores or disrupting the lipid bilayer. This leads to cell lysis, where the cell membrane becomes permeable and the cell contents leak out, causing cell death.
2. Induction of Apoptosis : Melittin can trigger programmed cell death (apoptosis) in cancer cells. It activates various signaling pathways that lead to the activation of caspases, enzymes that play a crucial role in the apoptosis process.
3. Inhibition of Cell Proliferation : Melittin can inhibit the proliferation of cancer cells by interfering with cellular signaling pathways that regulate cell growth and division. This can prevent the cancer cells from multiplying.
4. Inhibition of Angiogenesis : Melittin has been shown to inhibit the formation of new blood vessels (angiogenesis) that tumors need for growth and metastasis. By reducing the blood supply to the tumor, melittin can starve the cancer cells of necessary nutrients and oxygen.
5. Disruption of Cellular Signaling: Melittin can interfere with various signaling molecules and pathways within cancer cells, such as the PI3K/Akt pathway, which is often upregulated in cancer. This disruption can lead to reduced cell survival and increased sensitivity to other treatments.
Overall, melittin’s ability to target cancer cells selectively while sparing normal cells is a key factor in its potential as an anti-cancer agent. However, further research and clinical trials are necessary to fully understand its mechanisms and to develop safe and effective therapeutic applications.
Experiences : Entomologist | Pest Control Specialist | Mosquito Control Expert | Disease Vector Controller: Navigating the Frontline of Health Defense | Environmental Social and Governance Compliance | Agriculturist |
Breakthrough Discovery: Bee Venom Kills Cancer Cells!
Exciting news in the fight against cancer!
Researchers have made a groundbreaking discovery that bee venom can destroy aggressive breast cancer cells in a lab setting!
The venom, and a compound in it called melittin, have shown remarkable effectiveness against two hard-to-treat cancer types: triple-negative and HER2-enriched.
But how does it work? Melittin creates holes in the cell membrane, killing cancer cells in under 1 hour!
This innovative finding could lead to new treatments and hope for cancer patients.
#beevenom#cancerresearch#breastcancer#melittin#innovation#science#nature#healthcare#cancertreatment#breakthrough
Memorial Sloan Kettering Cancer Center (MSK) researchers are making strides against cancer every day. Their latest research investigates overcoming drug resistance in chronic lymphocytic leukemia; describes a new method for identifying driver mutations in tumor samples; identifies a protein that orchestrates macrophages’ cancer-fighting abilities; and uncovers how cancer programs could do more to help patients quit smoking.
Read more about each of them here: https://bit.ly/49ziiiR
Despite remarkable advances in cancer treatment in recent decades, cancer remains the leading cause of death. At #TeamBayer we are committed to fighting cancer and advancing our research to discover novel therapies. Our goal is to improve current treatments and develop new innovative therapies.
In this #SciencePodcast you will learn more about the unsolved challenges facing cancer patients. Discover how genetic testing and artificial intelligence are revolutionizing cancer diagnosis and immunotherapies can transform cancer treatment.
A ray of hope in cancer research: A melanoma cancer vaccine with minimal side effects is nearing phase 3 trials. 💉🔬
◾ This promising development could significantly advance melanoma treatment, offering new hope to patients worldwide.
◾ As we navigate the complex landscape of cancer research, each breakthrough brings us one step closer to a cure. 💡🌐
◾ Join us as we discuss this significant advancement and its potential impact on cancer treatment.
#CancerResearch#MelanomaVaccine#MedicalBreakthroughhttps://lnkd.in/eXzEFcis
🔬We'd like to share information about a cancer research experiment currently being conducted in our research labs in Wattwil.
🌱Extract of the plant Laminaria is being tested on a breast cancer cell line panel for its impact on cancer development. We would like to know if Laminaria can influence epigenetic mechanisms involved in development of cancer.
The general aim of the experiment is to investigate changes in miRNA expression levels using plant extracts.
💡Exosomal miRNAs and exosomes are now one of the most promising approaches for cancer diagnosis and target treatment.
🔬 Highlighting TAR-200: Prof. Andrea Necchi's Perspective on Cancer Treatment Advances
Oncology Frontier brings you an insightful overview of the TAR-200 delivery system, a promising development in cancer therapy, through the lens of Professor Andrea Necchi's expertise. As a distinguished figure in oncological research, Professor Necchi's analyses and perspectives are invaluable in understanding the significance of TAR-200 in modern cancer treatment.
Dive into our feature to discover how this innovative system could revolutionize oncology.
🔹 What are the unique benefits of TAR-200 in cancer therapy, as explained by Professor Necchi?
#OncologyInnovation#TAR200#CancerResearch#MedicalAdvances#ESMO#HealthcareFuture
Executive Clinical Development & Medical Affairs Leader Specialized in Rare Disease, CNS Disorder, & Oncology Expertise | Key Opinion Leader Collaboration
2wI virtually attended the workshop. Good insight.